Persistent lymphopenia after diagnosis of sepsis predicts mortality

Shock

Volumn 42, Issue 5, 2014, Pages 383-391

  Drewry, Anne ^a   Samra, Navdeep ^a   Skrupky, Lee ^b   Fuller, Brian ^a,c   Compton, Stephanie ^a   Hotchkiss, Richard ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES JEWISH HOSPITAL   (United States)

^c WASHINGTON UNIVERSITY   (United States)

Author keywords

absolute lymphocyte count; bacteremia; immunomodulation; Immunosuppression; survival

Indexed keywords

ADULT; APACHE; ARTICLE; BACTEREMIA; BLOOD CELL COUNT; BLOOD CULTURE; COHORT ANALYSIS; COMORBIDITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; PERSISTENT LYMPHOPENIA; RETROSPECTIVE STUDY; SECONDARY INFECTION; SEPSIS; SURVIVOR; TERTIARY CARE CENTER; AGED; COMPLICATION; EPIDEMIOLOGY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; KAPLAN MEIER METHOD; LYMPHOPENIA; OPPORTUNISTIC INFECTION; PROGNOSIS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; AGED; APACHE; BACTEREMIA; FEMALE; HUMANS; IMMUNE TOLERANCE; KAPLAN-MEIER ESTIMATE; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOPENIA; MALE; MIDDLE AGED; MISSOURI; OPPORTUNISTIC INFECTIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SEPSIS;

EID: 84930084195     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000234     Document Type: Article

References (43)

1. Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Crit Care Med 40(3): 754-761, 2012
2. Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163(2): 316-321, 2001
3. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med 348(2): 138-150, 2003
4. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 369(9): 840-851, 2013
5. Ward PA. Immunosuppression in sepsis. JAMA 306(23): 2618-2619, 2011
6. Torgersen C, Moser P, Luckner G, Mayr V, Jochberger S, Hasibeder WR, Dunser MW. Macroscopic postmortem findings in 235 surgical intensive care patients with sepsis. Anest Analg 108(6): 1841-1847, 2009
7. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, et al. Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306(23): 2594-2605, 2011
8. Schefold JC, Hasper D, Volk HD, Reinke P. Sepsis: time has come to focus on the later stages. Med Hypotheses 71(2): 203-208, 2008
9. Hotchkiss RS, Swanson PE, Freeman BD, Tinsley KW, Cobb JP, Matuschak GM, Buchman TG, Karl IE. Apoptotic cell death in patients with sepsis, shock, and multiple organ dysfunction. Crit Care Med 27(7): 1230-1251, 2009
10. Venet F, Davin F, Guignant C, Larue A, Cazalis MA, Darbon R, Allombert C, Mougin B, Malcus C, Poitevin-Later F, et al. Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 34(4): 358-363, 2010
11. Monserrat J, de Pablo R, Reyes E, Diaz D, Barcenilla H, Zapata MR, de la Hera A, Prieto A, Alvarez-Mon M. Clinical relevance of the severe abnormalities of the T cell compartment in septic shock patients. Crit Care 13(1): R26, 2009
12. Hein F, Massin F, Cravoisy-Popovic A, Barraud D, Levy B, Bollsert PE, Gibot S. The relationship between CD4+CD25+CD127j regulatory T cells and inflammatory response and outcome during shock states. Crit Care 14(1): R19, 2010
13. Monserrat J, de Pablo R, Diaz-Martin D, Rodriguez-Zapata M, de la Hera A, Prieto A, Alvaraez-Mon M. Early alterations of B cells in patients with septic shock. Crit Care 17(3): R105, 2013
14. Inoue S, Suzuki-Utsunomiya K, Okada Y, Taira T, Iida Y, Miura N, Tsuji T, Yamagiwa T, Morita S, Chiba T, et al. Reduction of immunocompetent T cells followed by prolonged lymphopenia in severe sepsis in the elderly. Crit Care 41(3): 810-819, 2013
15. Felmet KA, Hall MW, Clark RS, Jaffe R, Carcillo JA. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure. J Immunol 174(6): 3765-3772, 2005
16. Cheadle WG, Pemberton RM, Robinson D, Livingston DH, Rodriguez JL, Polk HC Jr. Lymphocyte subset responses to trauma and sepsis. J Trauma 35(6): 844-849, 1993
17. Oberholzer C, Oberholzer A, Bahjat FR, Minter RM, Tannahill CL, Abouhamze A, LaFace D, Hutchins B, Clare-Salzler MJ, Moldawer LL. Target adenovirusinduced expression of IL-10 decreases thymic apoptosis and improves survival in murine sepsis. Proc Natl Acad Sci U S A 96(20): 14541-14546, 2001
18. Hotchkiss RS, Tinsley KW, Swanson PE, Change KC, Cobb JP, Buchman TG, Korsmeyer SJ, Karl IE. Prevention of lymphocyte cell death in sepsis improves survival in mice. Proc Natl Acad Sci U S A 96(25): 14541-14546, 1999
19. Meisel C, Shefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J, Weber-Carstens S, Hasper D, Keh D, Zuckermann H, et al. Granulocyte-macrophage colony-stimulating factor to reverse sepsis-Associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180(7): 640-648, 2009
20. Hall MW, Knatz NL, Vetterly C, Tomarello S, Wewers MD, Vold HD, Carcillo JA. Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome. Intensive Care Med 37(3): 525-532, 2011
21. Angus DC. The search for effective therapy for sepsis: back to the drawing board? JAMA 306(23): 2614-2615, 2011
22. Lewis RT, Klein H. Risk factors in postoperative sepsis: significance of preoperative lymphocytopenia. J Surg Res 26(4): 365-371, 1979
23. de Jager C, van Wijk P, Mathoera RB, de Jongh-Leuvenink J, van der Poll T, Wever PC. Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Critical Care 14(5): R192, 2010
24. Heffernan DS, Monaghan SF, Thakkar RK, Machan JT, Cioffi WG, Ayala A. Failure to normalize lymphopenia following trauma is associated with increased mortality, independent of the leukocytosis pattern. Crit Care 16(1): R12, 2012
25. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; for the STROBE Initiative: The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Int Med 147(8): 573-577, 2007
26. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G. International Sepsis Definitions Conference: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29(4): 530-538, 2003
27. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM, Sprung CL, Colardyn F, Blecher S. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Crit Care Med 26(11): 1793-1800, 1998
28. Vincent JL, Moreno R, Takala J, Willatts S, de Mendonc'a A, Bruining H, Reinhart CK, Suter PM, Thijs LG. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Med 22(7): 707-710, 1996
29. for the Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19): 1368-1377, 2001
30. Venet F, Chung CS, Monneret G, Huang X, Garber M, Ayala A. Regulatory T cell populations in sepsis and trauma. J Leukoc Biol 83(3): 523-535, 2008
31. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW. Downregulation of proinflammatory cytokine release from whole blood from septic patients. Blood 85(5): 1341-1347, 1995
32. Weighardt H, Heidecke CD, Emmanuilidis K, Maier S, Bartels H, Siewert JR, Holzmann B. Sepsis after major visceral surgery is associated with sustained and interferon-gammaYresistant defects of monocyte cytokine production. Surgery 127(3): 309-315, 2000
33. Rigato O, Salomao R. Impaired production of interferon-gamma and tumor necrosis factor-Alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 19(2): 113-116, 2003
34. Sinistro A, Almerighi C, Ciaprini, Natoli S, Sussarello E, Di Fino S, Calò-Carducci F, Rocchi G, Bergamini A. Downregulation of CD40 ligand response in monocytes from sepsis patients. Clin Vaccine Immunol 15(12): 1851-1858, 2008
35. Munoz C, Carlet J, Fitting C, Misset B, Blériot JP, Cavaillon JM. Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88(5): 1747-1754, 1991
36. Monneret G, Lepape A, Voirin N, Bohé J, Venet F, Debard AL, Thizy H, Bienvenu J, Gueyffier F, Vanhems P. Persisting low monocyte human leukocyte antigen-DR expression predicts mortality in septic shock. Intensive Care Med 32(8): 1175-1183, 2006
37. Monneret G, Elmenkouri N, Bohé J, Debard AL, Gutowski MC, Bienvenu J, Lepape A. Analytical requirements for measuring monocytic human lymphocyte antigen DR by flow cytometry: application to monitoring of patients with septic shock. Clin Chem 48(9): 1589-1592, 2002
38. Volk HD, Reinke P, Krausch D, Zuckermann H, Asadulla K, Müller JM, Dncke WD, Kox WJ. Monocyte deactivationVrationale for a new therapeutic strategy in sepsis. Intensive Care Med 22(Suppl 4): S474-S481, 1996
39. Dncke WD, Randow F, Syrbe U, Krausch D, Asadulla K, Reinke P, Volk HD, Kox W. Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3(6): 678-681, 1997
40. Unsinger J, McGlynn M, Kasten KR, Hoekzema AS, Watanabe E, Muenzer JT, McDonough JS, Tschoep J, Ferguson TA, McDunn JE, et al. IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 184(7): 3768-3779, 2010
41. Unsinger J, Burnham CA, McDonough J, Morre M, Prakash PS, Caldwell CC, Dunne WM Jr, Hotchkiss RS. Interleukin-7 ameliorates immune dysfunction and improves survival in a 2 hit model of fungal sepsis. J Infect Dis 206(4): 606-616, 2012
42. Brahmamdam P, Inoue S, Unsinger J, Chang KC, McDunn JE, Hotchkiss RS. Delayed administration of antiYPD-1 antibody reverses immune dysfunction and improves survival in sepsis. J Leukoc Biol 88(2): 233-240, 2010
43. Zhang Y, Zhou Y, Lou J, Li J, Bo L, Zhu K, Wan X, Deng X, Cai Z. PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction. Crit Care 14(6): R220, 2010